7.595USD-3.25%Mkt Cap: 235.94M USDP/E: —Last update: 2026-06-01
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and L…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap235.94M USD
Enterprise Value-13.77M USD
Revenue (TTM)20.99M USD
Gross Profit18.67M USD
Net Income (TTM)-82.13M USD
Revenue/Share0.7050 USD
Last Price7.595 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees152
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.24
PEG—
EV/EBITDA0.12
EV/Revenue-0.66
P/S11.62
P/B0.99
EPS (TTM)-3.64
EPS (Forward)-3.47
52W Range
6.6102% of range50.40
52W High50.40 USD
52W Low6.610 USD
Profitability
Gross Margin97.81%
Oper. Margin-2321.67%
EBITDA Margin0.00%
Profit Margin-430.25%
ROE-28.88%
ROA-26.85%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-69.17M USD
CapEx (TTM)827.00K USD
FCF Margin-232.57%
FCF Yield-20.69%
Net Debt-257.71M USD
Net Debt/EBITDA2.18
Balance Sheet
Debt/Equity0.00
Current Ratio10.40
Quick Ratio10.11
Book Value/Sh7.861 USD
Cash/Share8.241 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 21, 2024
Splits
Last Split1:7
Split DateMar 22, 2024
Analyst Consensus
Rating—
Target (Mean)32.00 USD
Target Range—
# Analysts—
Ownership
Shares Out.31.35M
Float18.48M
Insiders2.65%
Institutions107.78%
Short Interest
Short Ratio12.4d
Short % Float58.29%
Short % Out.35.39%
Shares Short11.10M
Short (prev mo.)9.48M
Technical
SMA 509.096 (-16.5%)
SMA 20022.45 (-66.2%)
Beta1.67
S&P 52W Chg27.94%
Avg Vol (30d)826.76K
Avg Vol (10d)833.68K
Technical Indicators
RSI (14)43.6
MACD-0.5284
MACD Signal-0.5970
MACD Hist.+0.0686
BB Upper10.36 USD
BB Middle8.213 USD
BB Lower6.065 USD
BB Width52.30%
ATR (14)0.6640 USD
Vol Ratio (20d)0.56x